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Abstract. Bullous congenital ichthyosiform erythro- 
derma (BCIE) is a dominantly inherited blistering skin 
disorder caused by point mutations in the suprabasal 
cytokeratins 1 or 10. Targeting the murine cytokeratin 
10 gene in ES ceils resulted in mice with different phe- 
notypes in the homozygotes and heterozygotes; both of 
which exhibit similarities to specific clinical characteris- 
tics of BCIE. Homozygotes suffered from severe skin 
fragility and died shortly after birth. Heterozygotes 
were apparently unaffected at birth, but developed hy- 
perkeratosis with age. In both genotypes, aggregation 
of cytokeratin intermediate filaments, changes in cyto- 
keratin expression, and alterations in the program of 
epidermal differentiation were observed. In addition 
we demonstrate, for the first time, the existence of the 
murine equivalent of human cytokeratin 16. 
I 
N certain cultured cells and tissues like skin, cytokera- 
tin intermediate filaments are among the most promi- 
nent  cytoskeletal proteins  (Fuchs  and  Green,  1978, 
1980; Franke et al., 1981). Ironically this has not helped to 
unravel  their  functions,  although  many  have  been sug- 
gested during two decades of intense research (e.g.: Traub, 
1985; Traub and Shoeman, 1994). Demonstration of a com- 
plete absence of cytoplasmic intermediate filaments in cul- 
tured cells (Venetianer et al., 1983) without a recognizable 
effect on basic cellular functions has hinted towards their 
involvement in development and differentiation but also 
stressed the requirement for more complex experimental 
systems, such as animal models, to study their function. 
For structural  reasons, the ~20 epithelial cytokeratins 
and N10 hair keratins were grouped into the type I and II 
classes  of intermediate  filaments  proteins  (Moll  et  al., 
1982; Schiller et al., 1982; Fuchs and Weber, 1994). Unlike 
most other intermediate filaments proteins, the expression 
of the two cytokeratin classes is highly  regulated during 
development and  in tissue differentiation, with anything 
between 2 and 11 cytokeratins in the same cell. They form 
obligatory copolymers of equimolar amounts of at least 
one member of each class  (Moll et al.,  1982; Sun et al., 
1984). Whereas in vitro an unlimited promiscuity between 
any type I and II is possible (Hatzfeld and Franke, 1985), 
the  patterns  of  cytokeratin  expression  in  vivo  are  re- 
stricted (Moll et al., 1982; Sun et al., 1984), suggesting dis- 
tinct functions for various cytokeratin pairs.  All basal ke- 
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ratinocytes of stratified epithelia, for example, synthesize 
predominantly cytokeratins 5 and 14, with minor amounts 
of cytokeratin  15  (Moll et al.,  1982; Leube et al.,  1988; 
Lloyd et al., 1995), which upon terminal differentiation of 
skin are sequentially replaced by cytokeratins 1, 2e, and 10 
(Fuchs and Green, 1980; Collin et al., 1992). 
Like in other intermediate filament subunits the ends of 
the cytokeratin rod domains are highly conserved and be- 
lieved to be essential for correct assembly (Coulombe and 
Fuchs, 1990; Hatzfeld and Weber, 1991, 1992). Mutations 
in these domains or their complete removal lead to a col- 
lapse  of intermediate  filaments  (Albers and Fuchs,  1987, 
1989; Hatzfeld  and  Weber,  1990; Wilson  et  al.,  1992), 
whereas amino acid alterations along the rod seem to in- 
terfere less with intermediate filaments stability. 
The logical  extension of previous work on cytokeratin 
domain  analysis  (Albers and Fuchs,  1987, 1989)  has re- 
sulted  in  transgenic  mice  that  overexpress considerable 
amounts of truncated, peptide-tagged cytokeratin 14 sub- 
units  in  the  basal  layer  of epidermis  (Coulombe et  al., 
1991b). Such truncated subunits collapse existing filaments, 
acting  as  dominant-negative  chain  terminators  (Hersh- 
kowitz, 1987). The mice overexpressing truncated cytoker- 
atin 14 developed fragile skin with extensive blistering and 
aggregation of cytokeratin filaments in the basal epider- 
mal compartment, resembling epidermolysis bullosa sim- 
plex (EBS)  1, a  human inherited  skin disease with previ- 
ously unknown aetiology (Anton-Lamprecht,  1978). This 
has stimulated the search for point mutations in epidermal 
cytokeratin genes of patients with mostly dominantly in- 
herited skin disorders. These include EBS (cytokeratins 5 
1. Abbreviations used in this paper. BCIE, bullous congenital ichthyosi- 
form erythroderma; EBS, epidermolysis bullosa simplex; PGK, phospho- 
glycerate-kinase. 
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al.,  1992),  epidermolytic palmoplantar keratoderma (cy- 
tokeratin 9; Reis et al., 1994; Torchard et al., 1994), pachy- 
onychia congenita (cytokeratins 6, 16, or 17; Bowden et al., 
1995; McLean et al., 1995), ichthyosis buUosa of Siemens 
(cytokeratin 2e; Kremer et al.,  1994; McLean et al., 1994; 
Rothnagel et al., 1994)  and bullous congenital ichthyosi- 
form erythroderma (BCIE; cytokeratins 1 or 10; Chipev et 
al., 1992; Rothnagel et al.,  1992). The majority of muta- 
tions  found  so  far  in  the  different cytokeratins cluster 
around the conserved helical domains with a few in other 
domains except the tail (McLean and Lane, 1995). 
Common to all these disorders is the aggregation/alter- 
ation of cytokeratin filaments that leads to cytolysis and 
blistering. The cytokeratin carrying the mutation clearly 
dictates the layer of the epidermis affected and determines 
some  of the  clinical features  that  distinguish these  dis- 
eases.  There  is  considerable  variation,  however,  within 
these diseases in the severity, onset and the body sites in- 
volved (Anton-Lamprecht, 1994; DiGiovanna and Bale, 
1994; McLean and Lane, 1995). It is not yet clear whether 
these differences can be correlated to the position of a 
given mutation in the relevant cytokeratin gene. 
BCIE is caused by point mutations in either cytokeratin 
1 or 10 (Cheng et al., 1992; Chipev et al., 1992; Rothnagel 
et al., 1992), which are expressed in the suprabasal epider- 
mis. Histological features include cytokeratin filament ag- 
gregation,  alteration  of nuclear  shape,  vacuolization of 
spinous  and  granular  layer keratinocytes  and  cytolysis. 
Clinically BCIE includes localized or extensive blistering 
with denudation in severe cases as well as acanthosis and 
hyperkeratosis (Traupe, 1989; Ishida-Yamamoto et al., 1992; 
Anton-Lamprecht, 1994). As in other cytokeratin-related 
disorders that show hyperkeratosis, the link between cy- 
tokeratin mutations and cell proliferation is unclear. Com- 
plicated by erythroderma and secondary infections of the 
upper epidermis this disorder is very debilitating and disfig- 
uring. 
So far a limited number of mouse models to study inter- 
mediate filaments functions have been generated includ- 
ing conventional transgenic mice overexpressing either in- 
tact  or truncated cytokeratins in  appropriate  or  ectopic 
sites (Coulombe et al., 1991b; Vassar et al., 1991; Fuchs et 
al., 1992; Blessing et al.,  1993; Rothnagel et al., 1993; A1- 
bers et al., 1995). Although mice overexpressing cytokera- 
tin 10/14 hybrid or cytokeratin 14 truncations developed 
phenotypes with some similarity to EBS or BCIE (Cou- 
lombe et al., 1991b; Vassar et al., 1991; Fuchs et al., 1992), 
they suffered from copy number and position effects of 
conventional  transgenes.  It  remains  difficult  to  decide 
whether  unbalanced  and/or  overexpression  of  cytoker- 
atins or cytokeratin fragments represent  gain or loss of 
function phenotypes.  Since  recently  reported  knockout 
mice that lacked the type III intermediate filaments pro- 
teins  vimentin  (Colucci-Guyon  et  al.,  1994)  or  GFAP 
(Gomi et al., 1995; Pekny et al., 1995) showed no recogniz- 
able phenotype, the discussion of intermediate filaments 
function has been reopened. However, the demonstration 
of mid-gestational lethality of cytokeratin 8 knockout mice 
(Baribault et al., 1993, 1994) and two extremely rare cases 
of EBS patients lacking cytokeratin 14 in their basal epi- 
dermis (Chan et al., 1994; Rugg et al., 1994) suggested that 
cytokeratin intermediate filaments do play essential roles. 
Such patients, however, cannot provide reasonable models 
to study the biology of disease. Support for the require- 
ment of cytokeratin also came from recently published cy- 
tokeratin 14 knockout mice (Lloyd et al., 1995). 
In the present study, we have initiated a mouse model 
for BCIE by targeting the mouse cytokeratinlO gene in ES 
cells. Homozygous and heterozygous cytokeratin 10 knock- 
out mice develop a phenotype with histological and ultra- 
structural similarity to BCIE and reveal the previously un- 
certain existence of the murine cytokeratin -16, a marker 
for wound healing, repair, and hyperproliferation (Weiss 
et al., 1984). 
Materials and Methods 
Construction of the Targeting Vector 
The targeting vector was constructed from a  6-kb BamHI fragment in- 
cluding cytokeratin 10 sequences starting at bp 246 (these data available 
from GenBank under accession number M10081). This fragment was ob- 
tained from an 129/ola-derived genomic DNA library (constructed by T.M. 
Magin), by screening with a probe containing 330 bp of the 3' nontrans- 
lated region of the human cytokeratin 10 gene (kindly provided by W.W. 
Franke, German Cancer Research Centre, Heidelberg, Germany). 
The targeting vector contains two  arms of mouse cytokeratin  10 ge- 
nomic DNA; a  5'- 1.2-kb SmaI-EcoRI fragment and a  3'- 2.7-kb XhoI- 
BamHI fragment, separated by the phosphoglycerate-kinase (PGK) pro- 
moter-driven HPRT minigene (PGK/pDWM1) (Magin et al., 1992).  The 
HPRT minigene replaces exons 3-7 and is in the antisense orientation 
with respect to the cytokeratin 10 transcription unit. This construct was in- 
serted into a Bluescript II SK+ vector containing a Herpes simplex virus 
thymidine kinase gene. The targeting vector was linearized with XbaI, so 
that vector sequences were downstream of the thymidine kinase gene (see 
Fig.  1  a).  For  electroporation,  DNA  was purified  by  Qiagen columns 
(Qiagen, Inc., Chatsworth, CA), followed by phenol/chloroform extrac- 
tion and ethanol precipitation. 
Cell Culture and Electroporation 
Culture conditions for the embryonic stem cell line HM-1, electroporation 
with linearized vector DNA, and selection of targeted colonies were de- 
scribed previously (Stacey et al., 1994). 
Preparation and Analysis of Genomic DNA 
Colonies surviving the HAT/ganciclovir selection regime were transferred 
into 24-well plates (Falcon Plastics, Cockeysville, MD) and approximately 
half of each was used for PCR analysis (Selfridge et al., 1992). The primers 
used were specific for the sequence upstream of the SmaI site of cytokera- 
tin 10: ATGGCAACTCAAGCCAGCGAG (these sequence data avail- 
able under GenBank accession number M10081 nucleotides 724-744) and 
for the HPRT minigene: AGCCTACCCTCTGGTAGA'ITGTCG (HPRT 
cDNA  sequence, positions 960-983).  Reaction  conditions were  as  de- 
scribed before (Selfridge et al., 1992) with the following time/temperature 
parameters: 30 s 94°C, 30 s 65°C and 1 min 72°C. An Omnigene thermocy- 
cler (Hybaid, Teddington, UK) was used. Taq polymerase was purchased 
from GIBCO  BRL (Gaithersburg, MD).  Genomic DNA from colonies 
that produced a PCR product was isolated from confluent ES cell cultures 
by proteinase K and RNAase A  digestion at 37°C overnight, followed by 
phenol/chloroform extraction and ethanol precipitation. Genomic South- 
ern blotting was carried out under stringent conditions (washes at 68°C in 
0.1 x  SSC) to analyze the structure of the targeted allele by hybridization 
with three probes: (a) 3.5-kb downstream sequence outside the targeting 
vector; (b) the HPRT minigene, and (c) the 0.5-kb BamHI/SmaI fragment 
located upstream of the targeting vector. 
Preparation and Identification of Transgenic Mice 
Cells from colonies with the correct  DNA structure  as determined by 
PCR and genomic Southern analysis were injected into blastocysts from 
C57B16  mice and returned to  CBA or MF-1  recipients. Chimeras pro- 
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rying the targeted allele were identified by coat color and PCR of tail 
DNA (as described for ES cell colonies). F1 pups carrying the altered al- 
lele were interbred. Pups resulting from these matings were genotyped us- 
ing a  PCR assay of mouse tail DNA that included the two primers de- 
scribed  for  identifying  ES  cell  colonies  and  an  additional  primer 
downstream  of  the  EcoRl  site:  ACAGGAGGATGACGGTATACC 
(these data are available from Genbank under accession number L00193; 
positions 461~141).  This PCR reaction gave two products; one specific for 
the wild type (1.1 kb) and one for the altered allele (1.4 kb). 
RNA Analysis of  Litters 
The skin was removed from decapitated neonates after a 30-40-s immer- 
sion in distilled water at 65°C and snap frozen at -70 °C. Total RNA was 
extracted  as  described by  Chomczynski and  Sacchi  (1987)  with minor 
modifications. Aliquots (30 ~Lg) were loaded on 1.5% agarose gels in the 
presence of formamide/formaldehyde as denaturant and RNA was trans- 
ferred to Genescreen Plus membrane (Du Pont Co., Wilmington, DE). 
The 5' BamHf-Smaf fragment and the 3' nontranslated region of mouse 
cytokeratin  10 were  used as probes for cytokeratin 10 message. Probes 
used to examine expression levels of other cytokeratins included the 3' 
nontranslated region of mouse cytokeratins 1, 17, and 14 (all donated by 
Dr. H. Winter, German Cancer Research Centre, Heidelberg). Cytokera- 
tin 16 probes were prepared from a vector containing the human cytokera- 
tin 16 cDNA (donated by Prof. E.B. Lane, University of Dundee) by diges- 
tion with MscI and XbaI. The cytokeratin 16 probe coded for 120 bp of 
the tail domain. 
Protein Analysis of Skin 
Protein extracts enriched in cytoskeletal proteins were prepared from fro- 
zen skins by homogenization as described previously (Magin et al., 1983) 
in the presence of 2 mM PMSF. One- and two-dimensional gel electro- 
phoresis were carried out essentially as described (Magin et al., 1983). For 
separation by isoelectric focusing the ampholines (Sigma Chem. Co., St. 
Louis) pH 4-6 (0.6%), pH 5-8 (0.4%), pH 7-9 (0.6%), and 3.5-10 (0.4%) 
were used to allow better separation of basic cytokeratins. For nonequilib- 
rium  pH  gradient  electrophoresis,  broad-range  ampholines pH  3.5-10 
(2%) were used. Proteins were transferred electrophoretically to nitrocel- 
lulose membranes (0.2-p~m pore size; Schleicher and Schuell) in a semi-dry 
transfer cell (Bio-Rad, Richmond, CA) according to the manufacturer's 
instructions. The membrane was blocked with 1% fetal calf serum in Tris- 
buffered saline with Tween 20 (TBST) (10 mM Tris-HCl pH 8, 150 mM 
NaC1, 0.1% Tween 20) at room temperature and incubated with the pri- 
mary antibody diluted in TBST for 2 h. Primary antibody dilutions were as 
follows: DEK-10 (cytokeratin  10;  Dako  Ltd.,  Hamburg, FRG)  1:1,000; 
KG 8.60 (cytokeratins 1, 10; Sigma Chem.) diluted 1:4,000; LH2 (cytoker- 
atin 10; Lane et al., 1991) diluted 1:5; LL001 (cytokeratin 14; Purkis et al., 
1990)  diluted 1:5; LL025  (cytokeratin  16;  Lane et al,  1991)  diluted 1:5 
(LH2, LL001, and LL025 were donated by Prof. I.M. Leigh, Royal Lon- 
don Hospital). For detection an anti-mouse IgG alkaline phosphatase con- 
jugate (Promega Corp., Madison, Wl) was diluted 1:7,500  and detected 
using NBT and BCIP as recommended by the manufacturer. 
Immunofluorescence 
Frozen sections (5  i~m  thick)  of mouse skin were  fixed in  acetone  at 
-20°C for 10 min and blocked with 5% goat serum. All antibodies were 
diluted in 1% BSA in PBS. The primary antibodies dilutions were as fol- 
lows: EAB  904  (anti-cytokeratin  1; Ortho  Diagnostics, Neckargemtind, 
FRG)  undiluted, RKSE 60 (anti-cytokeratin 10, kindly provided by Dr. 
Ramaekers, Maastricht, The Netherlands) 1:20,  LL001 (anti-cytokeratin 
14) undiluted. A Texas-Red conjugated donkey anti-mouse IgG antibody 
diluted 1:200  (Jackson ImmunoResearch Labs., Inc., West Grove, PA), 
was used as the secondary antibody. Slides were mounted in Mowiol (Cal- 
biochem Novabiochem, La Jolla, CA) containing 0.1% Dabco. 
Transmission Electron Microscopy 
Skin samples were processed for electron microscopy as described (Eady, 
1985) with a few modifications. Briefly, primary fixation was for 48 h  at 
4°C in half strength Karnovsky fixative  (Karnovsky, 1965).  Specimens 
were post-fixed in 1.3% osmium tetroxide in distilled water for 2 h at 4°C. 
After dehydration in a graded ethanol series, specimens were embedded 
in epoxy resin (Taab 812) via propylene oxide. Semithin sections (0.5 p~m) 
and ultrathin sections (60-90 nm) were cut on a Reichert OMU-4 ultrami- 
crotome. Semithin sections were stained with Richardson's stain (Rich- 
ardson et al., 1960).  Ultrathin section were collected on pioloform-coated 
copper grids and double stained with 5%  uranyl acetate in ethanol and 
lead citrate (Reynolds, 1963).  Sections were viewed using a Jeol 100 CX 
transmission electron microscope (JEOL U.S.A. Inc., Peabody, MA). 
Results 
Isolation and Targeting of the Mouse 
Cytokeratin 10 Gene 
To achieve good gene targeting frequencies we reisolated 
the previously identified mouse cytokeratin 10 gene (Krieg 
et al.,  1985)  from an isogenic  129/ola DNA  genomic li- 
brary. To introduce several independent point mutations 
by our two-step gene replacement procedure (Stacey et 
al.,  1994) the targeting vector was designed to replace cy- 
tokeratin 10 exons 3-7 with an HPRT minigene (Fig. 1 a). 
Here we report on results after the first targeting step 3 
out of 96 selected colonies resistant  to HAT/ganciclovir 
yielded  a  PCR  product  diagnostic  for  gene  targeting. 
Southern blotting confirmed the structure expected for a 
homologous recombination event (Fig. 1 b), and ES cells 
from  one  clone  were  used  to  generate  chimeras  that 
showed germline transmission at a good frequency. Most 
results  were  derived  from  intercrosses  between  129/ 
C57B16 founder animals containing the cytokeratin 10 tar- 
geted allele and C57B16 or Balb/c mice. 
Homozygous Cytokeratin 10 Knockout Mice Show High 
Perinatal Lethality 
Mice heterozygous for the targeted cytokeratin 10 allele 
were intercrossed to study the phenotype of homozygous 
cytokeratin  10  knockout  mice.  Generally  homozygous 
mice exhibited very fragile skin with severe erosions and 
erythema. Skin loss and/or erythema were seen frequently 
on the ventral aspects surrounding the umbilicus, but also 
elsewhere on the body. Blisters appeared around the face, 
the forepaws and elsewhere on the trunk (Fig. 2 a). The 
extent of skin loss varied considerably, even within a single 
litter and in repeated litters from the same breeding pairs. 
These mice represented ~25% of all pups, arguing against 
intrauterine  loss.  Affected pups  died  a  few hours  after 
birth. When on rare occasions we noted pups being born, 
homozygotes appeared with little or no damage to their 
skins.  However, persistent grooming by their mother or 
other mice led to skin loss, offering a possible explanation 
for the variation in the extent of skin loss when the mice 
were found.  In  contrast to normal  or heterozygote ani- 
mals, the stomachs of homozygotes did not contain milk. It 
may be  significant  that  in  mice,  unlike  in  humans,  the 
esophagus and forestomach have stratified squamous epi- 
thelia (Hummel et al., 1966) that express cytokeratins 1/10 
(Schweizer et al., 1988). 
Heterozygous Cytokeratin 10 Knockout Mice Develop 
Severe Hyperkeratosis but Survive to Adulthood 
Pups  with  one targeted  allele usually  showed  a  normal 
phenotype at birth, although erythroderma was occasion- 
ally observed on the  forepaws. Hyperkeratosis was  first 
observed over the trunk region at the onset of hair growth 
Porter et al. Cytokeratin 10 Knockout," Mouse Model for BCIE  927 Figure 1.  (A, i) Structure  of the cytokeratin 10 locus. Arrows in- 
dicate the position of PCR primers used to identify the wild-type 
allele. Letters show positions  of key restriction  sites: S, SmaI; P, 
PstI; R, EcoRI, X, XhoI. (ii) The targeting vector consists of an 
HPRT minigene  (PGK/DWM1) flanked by two arms of homol- 
ogy to mouse cytokeratin 10: at the 5' end a 1.2-kb SmaI-RI frag- 
ment including  exon 2; at the 3' end an XhoI-BamHI fragment 
including exon 8 and 1.5 kb of sequence downstream of cytokera- 
tin 10. A thymidine kinase  gene (PGK/TK) is also included  for 
selection  against  random integration.  The vector was linearized 
such that the vector (pBTII) sequences  were downstream of the 
TK gene. (iii) The targeted locus; arrows indicate the position of 
the PCR primers used to identify the targeted allele. Probes used 
for Southern analysis are shown  as thick  lines underneath; (iv) 
the presumptive mRNA product, derived from exons 1, 2, and 8. 
(B) Southern analysis of wild-type,  heterozygote, and homozy- 
gore mice. DNA was digested  with PstI and labeled  with the 3' 
probe shown in (iii). (C) Northern analysis. Cytokeratin 10 RNA 
was detected using the 5' and 3' probes. Identical bands were ob- 
tained with both probes (5' probe shown). The normal allele ex- 
presses a product of 2.0 kb and the altered allele one of 1.1 kb. 
Cytokeratin 16 RNA was detected with a human probe coding 
for the carboxy-tail  domain.  Other cytokeratins were detected 
with mouse probes to the 3' nontranslated region. An actin probe 
was used to compare loading of total RNA. Northern blots for cy- 
tokeratin 10 were exposed for shorter times and performed in a 
separate gel than those for other cytokeratins. 
but improved shortly afterwards. From the third week on, 
most of the  heterozygotes developed hyperkeratosis and 
scaling on the feet, the ears and the tail, the latter with a 
distinctive  furrowed,  verrucuous  skin  (Fig.  2,  b-d).  Feet 
covered with  yellow crusts  that  healed  without  scarring 
were a distinct feature of mice (this is also a characteristic 
of BCIE patients, see Frost and Van Scott, 1966). The de- 
gree  of  scaling  and  hyperkeratosis  increased  with  age, 
again resembling the  human phenotype. Examination  of 
several animals revealed that the weight of heterozygous 
animals  was  only  ~2/3  of  normal  littermates  at  three 
months of age and beyond. The older heterozygous ani- 
mals were susceptible to loss of skin on the bristle pads. 
The expression of cytokeratins 1 and 10 is first detected in 
the embryo in the nasal region (embryonic day 13.5)  and 
the whisker pads (embryonic day 14.5) before general ex- 
pression in other regions of the skin (embryonic day 15.5) 
(Byrne et al., 1994).  The nose and bristle pads may there- 
fore be particularly sensitive to loss of cytokeratin 10 in 
the adult. Feeding through the bars of the cage and groom- 
ing would potentially exacerbate a weakness. Eye and skin 
infections were also more common in heterozygous adults 
than other adult animals which is probably due to bacterial 
or fungal growth in dead scaling skin as observed in pa- 
tients with BCIE (Baden, 1991). 
Changes in Skin Morphology and Aggregation 
of Cytokeratin Filaments in Cytokeratin 10 
Knockout Mice 
To examine the effect of the cytokeratin 10 knockout on 
the distribution and structure of cytokeratin filaments and 
their consequence for cell integrity, light and electron mi- 
croscopy of forepaw  epidermis  were  carried  out.  Com- 
pared to the wild-type the nonlesional suprabasal epider- 
mis  of heterozygote animals was  slightly  acanthotic  and 
hyperkeratotic (Fig. 3, a and b) with an increase of oedema- 
tous cells. The intercellular space in the upper spinous and 
the  granular layer was markedly widened.  Ultrastructur- 
ally spinous and granular cells showed alterations in  the 
distribution of cytokeratin filament bundles. Areas of fila- 
ment-free cytoplasm were seen next to abnormal cytoker- 
atin  aggregates  (Fig.  4  c).  These  cytokeratin  aggregates 
were mostly located in the cell periphery, either close to 
the membrane or attached to desmosomes (Fig. 5, d and e). 
Remnants of intermediate filaments were also found asso- 
ciated with keratohyalin granules. The distribution of mi- 
tochondria and other organelles was not obviously altered 
in  the  heterozygous  cytokeratin  10  knockout  mice.  The 
size of the cytokeratin aggregates was generally smaller in 
mice than those in affected human tissue. We did not find 
perinuclear  shells  in  any  of the  sections,  in  contrast  to 
those described in various forms of BCIE (Traupe, 1989). 
As  in  BCIE  patients  the  basal  layer  was  unaffected  in 
knockout mice. 
Lesional  skin  of  homozygote  animals  was  markedly 
acanthotic and hyperkeratotic and the upper layers were 
abnormally translucent (Fig. 3 c). By electron microscopy 
many  spinous  and  granular  cells  showed  intracellular 
oedema formation and were lysed. The number of cyto- 
keratin  filament  bundles  appeared  to  be  markedly  re- 
duced (Fig. 4 d), a  finding confirmed by our biochemical 
analyses (see below). The aggregates were distinctly smaller 
in homozygous than in heterozygous mice and had a ten- 
dency to round up (Fig. 5 e). Some of the remaining cyto- 
keratin bundles were ultrastructurally abnormal with short 
wire-like  filaments,  others  were  morphologically  incon- 
spicuous  and  tended  to  be  associated  with  desmosomes 
(Fig. 4 d) or close to the plasma membrane. Overall, the 
continuity of cytoplasmic intermediate filaments connect- 
ing  neighboring  cells  through  desmosomes was  severely 
disrupted.  The  transition  zone  between  granular  and 
cornified  layers was  broadened  with  many incompletely 
cornified cells in the lower most stratum corneum (Fig. 5, a 
and b). The cytoplasm of these cells contained remnant or- 
ganelles, indicating a disruption of the normal differentia- 
tion pathway. 
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gous mouse. Mice homozygous 
for the  targeted allele  exhibit 
large  areas  of skin  loss.  Het- 
erozygous mice (H) showed ex- 
tensive  hyperkeratotic  scaling 
of the skin on (b) tail, (c) paws, 
and (d) ears. A wild-type  (W) 
litter mate is shown on the left 
of each picture for comparison. 
Both mice were ,'~2 mo old. 
lmmunofluorescence Analysis of Homo- and 
Heterozygous Cytokeratin I0 Knockout Mice Indicates 
Changes in Suprabasal Cytokeratin Patterns 
During the preparation of frozen sections it was noted that 
the suprabasal epidermis of heterozygous and even more 
of homozygous mice did split off from the basal layer, thus 
confirming the skin fragility of live mice. When frozen sec- 
tions of back skin (Fig. 6), tail, or forepaw (not shown) of 
homozygous  cytokeratin  10  knockout  mice  were  incu- 
bated with several cytokeratin 10  antibodies,  no staining 
was observed. A  reduced, but clearly persistent,  level of 
staining with cytokeratin 1 antibodies was seen in sections 
stained in parallel, in agreement with several reports dem- 
onstrating reduced stability of unbalanced type I or II cy- 
tokeratins  (e.g., Kulesh et al.,  1989;  Lu and  Lane,  1990; 
Magin et al., 1990; Blessing et al., 1993). Although immuno- 
fluorescence analysis is not a quantitative technique, with 
other explanations like epitope masking as a formal possi- 
bility, our biochemical analysis confirmed a decrease in cy- 
tokeratin i  (see below). This is in contrast to the unaltered 
expression  of cytokeratin  5  in  cytokeratin  14  knockout 
mice (Lloyd et al., 1995).  As the terminal domains of cy- 
tokeratins 1/10 are sequentially removed during terminal 
differentiation of the epidermis (Fuchs and Green, 1980; 
Banks-Sehlegel, 1982), they might naturally be more sus- 
ceptible to proteolysis than those of cytokeratins 5 or 14 
when present in unequal amounts. 
In BCIE patients, the cytokeratin filament system of the 
basal cell layer is generally unaffected by changes in the 
suprabasal  layer  (Ishida-Yamamoto  et  al.,  1992).  Our 
studies showed a comparable level of cytokeratin 14 stain- 
ing  in  the  basal  layer  of back,  tail,  and  paw  skin  (not 
shown) in all genotypes with some suprabasal cell staining, 
in  accordance  with  published  data  (Schweizer,  1993). 
There was however no increase in cytokeratin 14 in supra- 
basal  cells  of  the  knockout  mice  as  a  potential  conse- 
quence of the targeted disruption of cytokeratin 10. 
Injection of newborn control and cytokeratin 10 knock- 
out mice with bromodeoxyuridine and detection by anti- 
bromodeoxyuridine  antibodies  provided evidence for an 
increase  (~l.5-2-fold)  in  basal  cell  proliferation  in  the 
knockout  mice  (not  shown).  Similar  observations  were 
made in conventional transgenic mice expressing a  trun- 
cated  human cytokeratin  10/14  hybrid in  the  suprabasal 
epidermis (Fuchs et al., 1992) and in BCIE patients. Taken 
together  with  our  own  findings  in  the  cytokeratin  10 
Figure 3.  Light micrographs of semithin  (1 ~m) resin sections of murine paw skin showing epidermal changes in animals heterozygous 
(b) and homozygous (c) for the truncated cytokeratin 10 gene, in comparison to normal ridged skin (a) of wild-type animals. (a) Ridged 
epidermis comprises of 6--8 nucleated cell layers and a thin orthokeratotic stratum corneum. Epidermal buds are indicative of forming 
eccrine glands. (b) Lesional ridged skin is slightly acanthotic and hyperkeratotic with signs of incomplete cornification in places. (c) Peri- 
lesional ridged epidermis is markedly acanthotic and hyperkeratotic. Numerous suprabasal cells contain granular or fibrillar material. 
All, Richardson stain. Bars, 20 i~m. 
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sis of paw epidermis from wild- 
type (a), heterozygous (b), and 
homozygous  (c  and  d)  mice. 
(a) Normal ridged  epidermis. 
Cytokeratin  filament  bundles 
are  arranged  in  bundles  of 
varying length. Note the prom- 
inent  keratohyalin  granules 
(arrowheads).  bc,  basal  cell. 
(b) Spinous cell containing ar- 
eas of filament-free cytoplasm 
as well as abnormal  cytokera- 
tin aggregates (arrow). m, mi- 
tochondrion.  (c)  Granular 
cell. Note the overall  sparsity 
of cytokeratin filaments.  Re- 
maining  filaments  are  associ- 
ated with desmosomes (arrow- 
head)  and  keratohyalin  (kh). 
(d)  Overview. Basal  cells are 
normal.  Suprabasal  cells show 
electron dense irregularly shaped aggregates located near the cell membrane (arrows). Note the highly electron-lucent cytoplasm (as- 
terisk) of granular cells. Bars: (a and d) 2 p.m; (b and c) 0.5 ~m. 
knockout mice on the expression of the hyperproliferation 
marker cytokeratin 16 (see below) and those of Fuchs et 
al. (1992) regarding cytokeratin 6, this suggests that alter- 
ations in the organisation or expression of the hallmark su- 
prabasal cytokeratins 1, 2e, or 10 are the key events to trig- 
ger hyperproliferation. Understanding of the pathway by 
which  this  is  controlled remains  to  be  worked  out  and 
might provide a basis for therapy approaches. 
Biochemical Analysis Suggests a Basis for Different 
Phenotypes in Homo-and Heterozygous Cytokeratin 10 
Knockout Mice and Reveals the Existence of Mouse 
Cytokeratin 16 
To examine  the  cytokeratin pattern  in  homo-  and  het- 
erozygote cytokeratin 10 knockout mice we isolated total 
RNA from these mice and wild-type littermates for North- 
ern blotting and cytoskeletal proteins for two-dimensional 
gel analysis. Hybridization of RNA from all three geno- 
types with highly specific cytokeratin 10 probes showed 
the predicted 2-kb mRNA from the normal allele in wild- 
type and heterozygote mice. In the latter, this mRNA was 
reduced  significantly below the  predicted  level of 50%. 
Homozygotes showed  no wild-type sized cytokeratin 10 
RNA, even upon prolonged exposure time. Instead, an ad- 
ditional mRNA of 1.1 kb from the altered allele was de- 
tected with both the cytokeratin 10 5' probe (Fig. 1 c) and 
a  probe to the 3'  nontranslated region. Hybridization of 
the 1.1-kb transcript with this 3' probe suggested the pres- 
ence of exon 8. This is possible only if the HPRT minigene 
has been spliced out (Fig.  1 a). Indeed, an HPRT probe 
did  not  bind  to  the  1.1-kb  RNA  upon  reprobing  (not 
shown). The size of this transcript is consistent with the 
predicted size of exons 1, 2, and 8 (1.08 kb). 
When we examined the levels of cytokeratin 1 RNA in 
skin samples from our mice we were surprised to find its 
level reduced in heterozygotes and to a greater extent in 
homozygotes (see Fig. 1 c). So far, there are no indications 
for crossregulatory mechanisms acting at the level of tran- 
scription between expression pairs for any of the many cy- 
tokeratins (Oshima, 1992). One possible explanation for a 
decrease  in  cytokeratin  1  mRNA  is  a  reduction  in  the 
number of intact suprabasal keratinocytes due to the cyto- 
lysis (see Fig. 3). Alternatively cytokeratin 1 may be down- 
regulated as part of a  response to stimulation by growth 
factors released during wound healing  (Mansbridge  and 
Hanawalt, 1988; Choi and Fuchs, 1990). 
In contrast, there is an increase in the level of cytokera- 
tin 14 mRNA (Fig. 1 c) that is easily explained by the in- 
crease in mitotic activity in the basal cell layer detected by 
bromodeoxyuridine staining. 
Changes are known to occur in cytokeratin 6/16 expres- 
sion  in  response  to  wound  healing  (Weiss  et  al.,  1984; 
Mansbridge  and  Knapp,  1987)  and  in  hyperproliferative 
diseases including BCIE (Weiss  et al.,  1984;  Finzi et al., 
1991; Ishida-Yamamoto et al., 1992; Wilson et al.,  1994). 
Although it has been suggested that there is no mouse cy- 
tokeratin 16 equivalent (e.g., Schweizer, 1993), we probed 
RNA from all genotypes with probes specific to cytoker- 
atins 16 and 17, which is usually expressed along with cy- 
tokeratins 6/16 (Moll et al.,  1982).  Weak signals for both 
cytokeratins were detected in  skin RNA from wild-type 
mice,  most likely from hair  follicles where  they are  ex- 
pressed. A  dramatic increase for both cytokeratins 16 and 
17 was detected in homozygous cytokeratin 10 knockout 
mice. Although the increase of cytokeratin 17 RNA seems 
even stronger than that of 16, one has to keep in mind that 
cytokeratin 16 was hybridized to a human probe. 
Next we  assessed  whether  the  changes  in  cytokeratin 
RNA profiles were translated into the corresponding pro- 
teins. Staining of cytoskeletal proteins by Coomassie Blue 
showed that suprabasal cytokeratins were among the most 
prominent proteins in wild-type mice (Figs. 7, a-c and 8). 
There was  a  marked decrease in  cytokeratin 10  in  het- 
erozygous and a complete absence in homozygous mice, in 
agreement with the Northern blot results. Another notice- 
able change was the reduction of cytokeratin 1 in hetero- 
and homozygous knockout mice, reflecting the decrease in 
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sis of the upper epidermis and 
cytokeratin  filaments  in wild- 
type (a and c) and homozygous 
(b, d, e) animals.  (a) Note the 
marked morphological changes 
between the uppermost granu- 
lar cell (gc) and the lowermost 
cornified cell (cc). The latter is 
a flattened anucleated cell with 
homogenous  electron-dense 
cytoplasm. Organelles and typ- 
ical type I/II keratohyalin (kh) 
granules as present in the cell 
layer below have disappeared 
completely. (b) In contrast ho- 
mozygous  animals show a broad 
transition zone of multiple lay- 
ers  of  incompletely  cornified 
cells. Their cytoplasm contains 
remnant organelles and shows 
a dappled pattern of electron- 
lucent  and  electron-dense  ar- 
eas. (c) Normal cytokeratin fil- 
ament  bundles  (arrowheads) 
and nuclear membrane (n) are 
arranged in parallel,  separated 
by  a  small  rim  of cytoplasm. 
The bundle is composed of in- 
dividual  cytokeratin aggregates 
resulting  in  a  characteristic 
fibrillar  pattern. (d) Abnormal 
cytokeratin  aggregates  in  su- 
prabasal  keratinocytes.  Cyto- 
keratin clumps (arrows) are lo- 
cated next to the cell membrane 
and in association with desmo- 
somes (arrowheads). Note the 
lack of normal cytokeratin fila- 
ment bundles in both cells,  n, 
nucleus.  (e) Higher magnifica- 
tion reveals that abnormal cy- 
tokeratin  aggregates  (arrows) 
consist of short cytokeratin filaments in a whorl-like configuration. Note the fibrillar  pattern in the periphery and the granular appear- 
ance in the center of the cytokeratin aggregates. Asterisk, intercellular space. Bars: (b, c, and e) 2 txm; (d) 1 ixm. 
its mRNA. It remains to be seen how the still considerable 
amounts of cytokeratin  1 are stabilized  in the suprabasal 
epidermis.  The level of basal cytokeratins was slightly in- 
creased (Figs. 7, g-i and 8). 
Therefore we examined changes in cytokeratin expres- 
sion  profiles  further  by the  more  sensitive  Western  blot 
technique. Blotting with a specific cytokeratin 10 antibody 
showed that cytokeratin 10 was reduced  in samples from 
heterozygote mouse skins (Fig. 7 e) as in our Northern blot 
results.  In accordance with  our Northern blot results  ho- 
mozygote samples showed a complete absence of cytoker- 
atin 10 protein using monospecific or broad-range mono- 
clonal antibodies (Fig. 7 f). We then searched for a potential 
cytokeratin 10 polypeptide (cytokeratin 10T) coded by ex- 
ons 1, 2, and 8 in the knockout mice. It would include the 
head domain, coil 1A, part of coil 1B, and the ultimate cy- 
tokeratin 10 amino acid encoded by exon 8. The predicted 
polypeptide should have an isoelectric point of 9.1  and a 
molecular  mass  of 27.5  kD.  This  very basic  polypeptide 
was  detected  in  NEpHGE  gels  of heterozygote and  ho- 
mozygote  cytoskeletal  proteins  (see  Fig.  8).  Unfortu- 
nately,  the  cytokeratin  10  antibody  LH  2  (Lane  et  al., 
1991) reacts with the carboxyterminus so we could not un- 
equivocally characterize cytokeratin 10T by Western blot- 
ting.  Several  other  cytokeratin  10  antibodies  showed  no 
reaction with  10T either.  It is however detectable  among 
proteins  translated  in vitro  from RNA of cytokeratin  10 
knockout  mice  but  not  from  wild-type  littermates  (not 
shown). Apart from the disappearance of intact cytokera- 
tin 10 the most dramatic changes occurred in the expres- 
sion of cytokeratin 16. We applied an antibody specific to 
human  cytokeratin  16  to see  whether  the  increase  in  its 
RNA was reflected into proteins as well. This antibody re- 
acted  very specifically with  a  cytokeratin  migrating  in  a 
position  expected  for cytokeratin  16,  which  is  increased 
dramatically  in heterozygotes and homozygotes (Fig. 7, l 
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type (a and d), hetero- (b and e), and homozygous (c and f) mice. 
Fixed cryosections were stained with monoclonal antibodies to 
cytokeratin 10 (a--c) or cytokeratin 1 (d-f). Note the complete ab- 
sence of cytokeratin 10 in homozygous mice and the persistent, 
albeit,  decreased staining for cytokeratin  1 in heterozygous  (e) 
and homozygous (f) mice. Bar, 50 p~m. 
and m) and present  as a  minor protein in wild-type mice. 
Taken  together  with  our RNA  data,  this  provides  strong 
evidence for the presence of cytokeratin  16 in the mouse. 
Nevertheless, in comparison to the massive amounts of su- 
prabasal cytokeratins, the total amounts of cytokeratins 16 
and  17  were  small in  cytokeratin  10 knockout  mice.  It is 
clear from the phenotype of cytokeratin 10 knockout mice 
and  the  electron  microscopy data  that  neither  these  two 
nor any other cytokeratins  present  in the  suprabasal  epi- 
dermis were able to compensate for the lack of cytokeratin 
10. This might have important implications for therapy ap- 
proaches  of  dominant  cytokeratin  disorders  based  on 
overexpression of cytokeratins. 
Discussion 
The targeted  disruption  of the cytokeratin 10 gene gener- 
ated mice in which the program of epidermal differentia- 
tion is severely and permanently  altered in homo- as well 
as in heterozygous  animals.  These  mice represent  a  very 
good  model  for  BCIE,  demonstrating  for  the  first  time 
that the absence of a functional cytokeratin 10 and not the 
overexpression  of normal or engineered  cytokeratin  sub- 
units  is  the  genetic  basis  for  the  disease.  In  conjunction 
with mice carrying knockouts for cytokeratins 8 (Baribault 
et  al.,  1993;  Baribault  et  al.,  1994)  and  14  (Lloyd  et  al., 
1995),  our mice clearly demonstrate  that  the  cytokeratin 
intermediate  filaments fulfil essential functions during de- 
velopment and tissue homeostasis.  It will be a  challenging 
task to see whether all the members of the complex cyto- 
keratin  gene family are functionally  important  and/or  in- 
terchangeable  and  whether  vimentin  (Colucci-Guyon  et 
al., 1994) or GFAP knockout mice (Gomi et al., 1995; Pekny 
et al., 1995) really lack a phenotype. Moreover, the hyper- 
keratosis  in  BCIE  and  in  our  cytokeratin  10  knockout 
mice suggests  that  cytokeratins  are involved in functions 
beyond maintaining structural integrity in epithelia. 
Similarity of the Mouse Model to BCIE 
Clinically  BCIE  patients  have  extremely  fragile  skin  at 
birth  with  blisters  and  ichthyotic  erythroderma.  During 
later life skin blistering and erythema tend to subside and 
acanthosis  and  hyperkeratosis  become  common  features 
(Traupe,  1989;  Anton-Lamprecht,  1994;  DiGiovanna  and 
Bale,  1994).  Ultrastructurally,  abnormal dumps or aggre- 
Figure 7.  Analysis of cytoskel- 
etal  proteins  by 2-D gel  elec- 
trophoresis  (isoelectric  focus- 
sing, IEF, for separation in the 
first  dimension  and  SDS- 
PAGE  in  the  second  dimen- 
sion).  (a, d, g, k) Cytoskeletal 
extracts from wild-type, (b, e, 
h,/) hetero-, and (c,f, i, m) ho- 
mozygous  mice.  (a--c)  Coo- 
massie-blue  stained  proteins. 
Note the complete absence of 
cytokeratin 10 in c (position in- 
dicated by arrow) and the con- 
comitant reduction of cytoker- 
atin 1 in b  and c. Arrowheads 
indicate  the  typical  processed 
products of cytokeratin 1.  (d- 
m)  Proteins  after  Western 
blotting with specific antibod- 
ies,  detected  with  alkaline 
phosphatase  and chromogenic 
substrates.  Individual  cyto- 
keratins are numbered accord- 
ing to Moll et al.  (1982).  (d-f) 
Detection of cytokeratin 10. Note the absence of cytokeratin 10 in homozygous mice (f, arrow). (g-i) Detection of cytokeratin 14. There 
is an increase in immunoreactive material in heterozygous and homozygous samples. The banding in i results from undissolved cytoker- 
atin 14 complexes in the first dimension electrophoresis. (k-m) Identification of murine cytokeratin 16. Low but detectable expression 
in wild-type mice (k), most likely from hair follicles.  Note a considerable increase in homozygous (rn) animals. B and A represent bo- 
vine serum albumin and actin, respectively, added as reference markers. In the Western blots the position of B and A was marked by 
pencil after Ponceau S staining of total proteins. 
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shells in otherwise translucent cells, are restricted to the 
upper spinous and the granular layer. Morphologically our 
cytokeratin 10 knockout mice exhibited two different phe- 
notypes  in  homo-  and  heterozygotes  that  complement 
each other to resemble BCIE (e.g., DiGiovanna and Bale, 
1994). The former had very fragile skin with small blisters 
and large areas of skin loss, particularly on the ventral sur- 
face and the forepaws and died soon after birth. The latter 
showed no clinical phenotype at birth but developed hy- 
perkeratosis and flaking of tail,  ear and foot epidermis. 
The restriction of hyperkeratosis to less hairy body sites 
and the observed transient hyperkeratosis of the body skin 
prior to the onset of fur growth suggest that hair follicles 
strenghten the skin. This was also observed in the cytoker- 
atin 14 knockout mice (Lloyd et al., 1995). Alternatively, it 
is possible that the intermediate filament cytoskeleton is 
more susceptible to constant mechanical strain in epithelia 
with an increased rate of cell turnover like the foot sole 
epidermis. 
The suprabasal cytolysis, oedema formation and hyper- 
keratosis typical of BCIE are clearly reproducible in mice. 
As judged by EM, there is only a  quantitative difference 
between  the  hetero-  and  homozygous  cytokeratin  10 
knockout mice.  Cytokeratin clumps  are  present in  both 
but they are smaller and fewer in homozygotes. Residual 
filamentous material  was  frequently attached  to  desmo- 
somes, close to the plasma membrane or associated with 
keratohyalin granules. The intracellular distribution of cy- 
tokeratin aggregates was somewhat different to findings in 
BCIE  patients  (e.g.,  Anton-Lamprecht  and  Schnyder, 
1974) and to transgenic mice overexpressing a  truncated 
human cytokeratin 10/14 hybrid (Fuchs et al., 1992). The 
reason behind this difference could be one of the follow- 
ing: first, it could be an intrinsic property of human cyto- 
keratins or their interaction with associated proteins. Hu- 
man  cytokeratins  could  function  inappropriately  when 
expressed in mouse tissue. Second, it may be due to the 
nature  of mutations  in  humans,  conventional transgenes 
and our cytokeratin 10 knockout mice being different. Al- 
though a number of cytokeratin mutations have been com- 
pared in cultured cells or in vitro (Letai et al., 1992, 1993), 
there are not yet sufficient data  from animal  models to 
conclude  on  their  effects  on  cytoskeletal  architecture. 
Thirdly, the overall amount of cytokeratins in our homozy- 
gous mice was drastically reduced. This in itself might alter 
the intracellular organization of the cytoskeleton. Resid- 
Figure 8.  Detection of truncated  cy- 
tokeratin 10 (cytokeratin 10T) in cy- 
toskeletal  extracts  from  hetero-  and 
homozygous mice (b and c) in compar- 
ison to wild-type mice (a). NEpHGE, 
nonequilibrium  gel electrophoresis  for 
separation  of proteins in the first  di- 
mension.  The position  of cylokeratin 
10T is  indicated  (arrow) in b  and  c. 
Trypsinogen (T, IEP 9.3; ~24 kD MW) 
was  added  as  an  additional  marker. 
Note the increase in cytokeratins 6 and 
16 and the reduction of cytokeratin 1 in 
the knockout mice (b-c). For other la- 
beling see Fig. 7. 
ual cytokeratins, whether bona fide intermediate filaments 
or assembled in an unknown fashion, have a tendency to 
attach to desmosomes as shown in our cytokeratin 10 and 
also in cytokeratin 14 (Lloyd et al., 1995) or 8 (Baribault et 
al.,  1993; Baribault et al., 1994) knockout mice but also in 
two rare cases of EBS, lacking functional cytokeratin 14 
(Chan et al., 1994; Rugg et al., 1994). This is strikingly sim- 
ilar to the first appearance of desmosomes and cytokeratin 
filaments in the early mouse embryo (Jackson et al., 1980). 
Whether  this  primarily  reflects  a  high  affinity between 
these structures or whether desmosomes represent some 
kind  of  cytokeratin  organizing  center  is  presently  un- 
known. 
The Genetic and Biochemical Basis for the Phenotype 
of Cytokeratin 10 Knockout Mice 
We have disrupted the cytokeratin 10 gene in mice by re- 
placing exons 3-7 with an HPRT minigene (Magin et al., 
1992; Selfridge et al., 1992) to prepare for the introduction 
of point mutations in a later second targeting step (for the 
procedure, see Stacey et al., 1994). Instead of generating a 
complete cytokeratin 10 null allele, this has led to a drasti- 
cally shortened cytokeratin 10 RNA coded by exons 1, 2, 
and 8  and an independent HPRT transcript that confers 
HAT resistance to targeted ES cells. In several indepen- 
dent RNA preparations from heterozygous mice there was 
more cytokeratin 10 RNA from the targeted than from the 
wild-type cytokeratin 10 allele. This could reflect more ef- 
ficient processing of the short RNA or its greater stability. 
It is possible on the other hand that the a priori assump- 
tion of equal expression from both alleles is not correct for 
all cytokeratin genes. In the light of known polymorphisms 
in some cytokeratin genes (Korge et al.,  1992a,b; Wanner 
et al., 1992) it seems possible that mutations in regulatory 
sequences exist that could modulate allelic expression. This 
can be analyzed in patient samples present in several labs. 
We have identified a shortened cytokeratin 10 polypep- 
tide (cytokeratin 10T) putatively comprising the head, 1A 
and 39 amino acids of the 1B domain that is probably en- 
coded by the short RNA. A very similarly sized predicted 
cytokeratin 14 polypeptide, generated by an in-frame stop 
codon in  a  recently described EBS patient  (Chan  et al., 
1994), could not be found among total or cytoskeletal pro- 
teins, probably due to the very low expression level of this 
protein and the relative instability of the mRNA. Although 
the presence of cytokeratin 10T in the cytoskeletal frac- 
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so far, the resulting changes in cytokeratin expression and 
epidermal differentiation in cytokeratin 10 knockout mice 
are remarkably similar to those occurring in the human 
disease. 
Does  the  cytokeratin 10T polypeptide act  as  a  domi- 
nant-negative in heterozygous mice? Without additional 
biochemical data it is difficult to say.  At first glance its 
presence in the cytoskeletal fraction seems to favor this 
view since it suggests formation of insoluble cytokeratin 
complexes. Either it is involved in heteromeric complexes 
with cytokeratin 1 (or another type II cytokeratin) as do 
corresponding fragments of cytokeratins 18/8 (Hatzfeld et 
al., 1987; Magin et al., 1987) which are deficient in further 
assembly steps or it forms homomeric complexes that pre- 
vent filament formation (Hatzfeld and Weber, 1991). Pre- 
vious experiments (Kouklis et al., 1991; Chipev et al., 1992; 
Hatzfeld and Weber, 1992) have shown that short peptides 
derived either from the H1 or the rod end domain can dis- 
assemble  intact intermediate filaments  or interfere with 
filament assembly. Unfortunately these experiments were 
only carried out in vitro using an excess of peptide that 
were much shorter than cytokeratin 10T. The structures 
observed in vitro were dearly different from those in our 
mice. Therefore an alternative mechanism might be con- 
sidered, adressing a fundamental issue of cytokeratin biol- 
ogy, namely the importance of the balance of natural cyto- 
keratin pairs. Could the phenotype be due to the unbalanced 
expression of cytokeratin 1, particularly in the homozygotes 
where we have detected significant amounts of cytokeratin 
i  in the absence of intact cytokeratin 10? This is very rem- 
iniscent of the ectopic expression of cytokeratin 1 in the 
pancreas  (Blessing  et  al.,  1993)  that  led  to  diabetes  in 
transgenic mice, whereas similar mice expressing cytoker- 
atin 10 in the same tissue were apparently normal. Taken 
together it seems possible that an excess of cytokeratin 1 is 
toxic to cells if not in heterotypic complexes with cytoker- 
atin 10. Future experiments will also address the question 
whether any of the other type I cytokeratins present in the 
upper epidermis (14, 15, 16, 17) might be involved in com- 
plex formation with cytokeratin 1, leading to filament ag- 
gregation. 
Finally it seems worthwhile to screen patients with se- 
vere forms of BCIE for truncations similar to the one we 
generated in our mice. 
The Cytokeratin 10 Knockout Changes Cytokeratin 
Expression Patterns and Epidermal Differentiation 
The overall amount of cytokeratin filaments and aggre- 
gates, as shown by EM and biochemical analyses, is clearly 
reduced in hetero- and even more in homozygous mice. 
Nevertheless the homozygous mice developed a far more 
severe  phenotype  indicating  an  inverse  correlation  be- 
tween severity of disease and size/number of cytokeratin 
aggregates. This would argue that the residual amount of 
functional cytokeratins rather than the size of cytokeratin 
aggregates (Coulombe et al., 1991b) determines the sever- 
ity of disease. 
We found increased expression of cytokeratins 16 and 
17 in the knockout mice. The detection of cytokeratin 16 is 
remarkable as it had been thought not to exist in mice be- 
fore (Schweizer, 1993; for a different observation see Ta- 
kahashi et al.,  1994). Although final confirmation has to 
await the cloning of mouse cytokeratin 16 our data pro- 
vide evidence for the conservation of cytokeratin expres- 
sion patterns  in mammals.  Expression of cytokeratin 16 
has  been documented before in  BCIE patients  (Ishida- 
Yamamoto et al., 1992) and cytokeratin 6 was shown to be 
expressed in transgenic mice overexpressing human cyto- 
keratin 10/14 hybrids (Fuchs et al., 1992). 
Hyperproliferation and  hyperkeratosis  develop in  cy- 
tokeratin 10 knockout mice as well as in BCIE patients. 
Again this is more pronounced in homozygous animals in 
which the balance between epidermal and hyperprolifera- 
tive cytokeratins is shifted towards the latter. The relation- 
ship between cytokeratin expression and hyperproliferation 
is not completely clear. Even though cytokeratin 6/cyto- 
keratin 16 expression is normally associated with hyper- 
proliferation, this cytokeratin pair is also expressed in non- 
proliferating tissue (Moll et al., 1982; McLean et al., 1995; 
and references therein). One possible explanation that has 
been suggested is that cytokeratin 6/cytokeratin 16 repre- 
sents an alternative differentiation pathway when it is not 
permissive for the normal differentiation to occur (Schermer 
et al., 1989). The molecular basis for hyperproliferation is 
presently unknown.  Among the large number of growth 
factors and cytokines involved in wound healing (McKay 
and Leigh, 1991) TGF alpha, that acts through the EGF 
receptor, is an attractive candidate. It appears to induce 
cytokeratin 6 and cytokeratin 16 expression through EGF 
response elements in the promoters of the genes for these 
cytokeratins (Jiang et al., 1993).  Interestingly, TGF alpha 
is elevated in the hyperproliferative skin of BCIE, squa- 
mous cell carcinoma, and psoriasis (Finzi et al., 1991). 
Implications for Therapy 
The cytokeratin 10 knockout mice provide convincing evi- 
dence that neither residual basal cytokeratins 5/14 nor cy- 
tokeratins 6/16/17 could rescue the phenotype. Similarly in 
conventional transgenic mice that  expressed quite  large 
amounts of truncated cytokeratin 10/14 hybrids (Fuchs et 
al., 1992) the expression of cytokeratin 6 (and probably 16/17 
as well), could not compensate for the phenotype caused 
by the  dominant-negative  effect of the  mutant  protein. 
This might be due to cell type-specific functions not ca- 
tered for by cytokeratins 6/16/17.  It is possible that these 
hyperproliferative cytokeratins are tailored to suit a tran- 
sient state like the one found in wound healing but not the 
needs of a stress-exposed epithelium like epidermis. Which 
options  (leaving aside the  issue  of epidermal stem cells 
and transfection efficiency) does that leave to treat BCIE 
or EBS? First, it still remains a possibility that overexpres- 
sion of the same cytokeratin subunit as the one mutated 
allows formation of normal intermediate filaments. This 
route would include overexpression of cytokeratin 1 or 10 
in BCIE. It is possible that rare, recessive cases of BCIE or 
mutations leading to a mild phenotype can be rescued in 
this way. Secondly, suppression of the mutant cytokeratin 
subunit expression by anti-sense technology seems feasi- 
ble in the light of recent transgenic experiments demon- 
strating rescue of a lethal pro-alphal(I) procollagen by ex- 
pression of a corresponding anti-sense construct (Khillan 
The Journal of Cell Biology, Volume 132, 1996  934 et al., 1994). As this approach is nonselective for the mu- 
tant and the wild-type allele an additional normal subunit 
of a different cytokeratin or the same cytokeratin from a 
different species needs to be expressed.  Thirdly, it might 
be possible to complement the function of mutant cytoker- 
atins by expression of a different intermediate filaments, 
e.g., class III subunit, as has been indicated by Lloyd et al. 
(1995). Based on the knowledge that cytokeratins do not 
copolymerize  with other intermediate  filaments  subunits 
this might be an effective strategy. 
Finally, with recent improvements in gene targeting fre- 
quencies (Melton, 1994), correction by this technology re- 
mains a potential option. All these approaches still need 
considerable experimental improvements, particularly re- 
garding techniques to introduce DNA efficiently into liv- 
ing epithelia. Our knockout mice should provide an attrac- 
tive sytem to explore some of these aspects. 
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